Three Dots Life Science Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-11-2024
- Paid Up Capital ₹ 2.15 M
as on 16-11-2024
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.78 Cr
as on 16-11-2024
- Revenue 4.11%
(FY 2023)
- Profit 9.67%
(FY 2023)
- Ebitda 12.33%
(FY 2023)
- Net Worth 49.56%
(FY 2023)
- Total Assets 22.12%
(FY 2023)
About Three Dots Life Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.15 M.
The company has closed loans amounting to ₹4.78 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Drawesh Jha and Archana Jha serve as directors at the Company.
- CIN/LLPIN
U51397BR2009PTC014516
- Company No.
014516
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 May 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Three Dots Life Science?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Drawesh Jha  | Managing Director | 18-May-2009 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Archana Jha | Director | 18-May-2009 | Current |
Financial Performance of Three Dots Life Science.
Three Dots Life Science Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.11% increase. The company also saw a slight improvement in profitability, with a 9.67% increase in profit. The company's net worth Soared by an impressive increase of 49.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Three Dots Life Science?
In 2022, Three Dots Life Science had a promoter holding of 99.39% and a public holding of 0.61%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Mar 2022 | ₹2.64 Cr | Satisfied |
Axis Bank Limited Creation Date: 04 Dec 2019 | ₹2.14 Cr | Satisfied |
How Many Employees Work at Three Dots Life Science?
Unlock and access historical data on people associated with Three Dots Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Three Dots Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Three Dots Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
